1.邱年永:原色藥用植物圖鑑(五),南天書局,台北 1986;250。
2.Narain NK: Spectroscopic studies of fasciculide-B, a new sesquiterpene lactone from the leaves of Vernonia fasciculata. Spectroscopy Lett. 1978; 11: 267.
3.Almagboul AZ, Bashir AK, Karim A, Salih M, Farouk A, Khalid SA: Antimicrobial activity of certain sudanese plants used in folkloric medicine. screening for antifungal action. Fitoterapia 1988; 59(5): 393-396.
4.Misra TW, Singh RS, Upadhiay J, Srivastava R: chemical constituents of Vernonia cinerea, Part I. Isolation and spectral studies of triterpenes. J Nat Prod 1984; 47(2): 368-372.
5.Grand Le: Anti-infectious phytotherapy of the tree-savannah, senegal (Western Africa) III: A review of the phytochemical substances and anti-microbial activty of 43 species. J Ethnopharmacol 1989; 25(3): 315-336.
6.De A, Ribeiro R, Fiuza. De, Melo Mmr, De Barros F, Gomes C, Trolin G: Acute antihypertensive effect in conscious rats produced by some medicinal plants used in the state of Sao Paulo. J Ethnopharmacol 1986; 15(3): 261-269.
7.Barrett B: Medicinal plants of Nicaragua''s Atlantic Coast. Econ Bot 1994; 48(1): 8-20.
8.台灣植物誌編輯委員會:台灣植物誌第二版(四),現代關係出版社 , 台北 1978;953-958。
9.張順治:嶺南野菊(Vernonia patula Merr.)化學成分之研究,中國醫藥學院中國藥學研究所碩士論文,台中1999。10.Parillo JE: Pathogenetic mechanisms of setptic shock. New Engl J Med 1993; 328: 1471-1477.
11.Rietschel ET, Brade H: Bacterial endotoxins. Sci Am 1992; 267: 54-61.
12.黃增泉:植物分類學,國立編譯館,台北 1993;411-415。
13.中山大學生物系,南京大學生物系:植物學之系統與分類,地景企業股份有限公司出版部,台北 1990;366-339。
14.侯寬照:中國種子植物科屬辭典,南天書局,台北 1991;512。
15.Fu CX, Xu YZ, Rui HK, Xin XJ: GC/MS study on the chemical compositions of the volatile oil from Vernonia anthelmintica Willd. Youfi Huaxue 1986; 5: 379-382.
16.Rustaiyan A, Niknejao A, Danieli B, Palhisano G, Jones S: Constituents of Vernonia westiniana. Fitoterapia 1977; 48 : 266.
17.Bohlmann F, Brindopke G, Rastogi RC: A new type of germacranolide from Vernonia species. Phytochemistry 1978; 17: 475-482.
18.Bohlmann F, Zdero C: Naturally occurring terpene derivatives. Constituents of Vernonia species. Phytochemistry 1977; 16: 778-779.
19.Asubiojo OI, Guinn VP, Okunuga A: Multielement analysis of nigerian chewing sticks by instrumental neutron activation analysis. J Radioanal Chem 1982; 74 :149-156.
20.Toubiana R, Ho CM, Mompon B, Toubiana MJ, Burlingame AL, Wilsoh DM: The structure of a poliacetylenic diol isolated from Vernonia appendiculata (Compositae). Experientia 1975; 31: 20-.
21.Tsichritzis F, Siems K, Jakupovic J, Bohlmann F, Mungai GM: sesquiterpene lactones from Vernonia jugalis. Phytochemistry 1991; 30(11): 3808-3809.
22.Lock DE Ugaz O, Fort Aste D: Triterpenes from Vernonia baccharoides. Bol Soc Quim Peru 1984; 50(3): 258-261.
23.Perez Souto N, Holup M, Budesihskt M: Phytochemical studies of Cuban species of the genus Vernonia. Rev Cubana Fam 1984; 18(3): 332-335.
24.Oketch-Rabah HA, Lemmich E, Dossaji SF, Theander TG, Olsen CE, Cornett C, Kharazmi A, Christensen SB: Two new antiprotozdal 5-methylcoucumarins from Vernonia brachycalyx. J Nat Prod 1997; 60(5): 458-461.
25.Bohlmann F, Ates N, Jakupovic J: Naturally occurring terpene derivatives. 464. hirsutinolides from South African Vernonia species.: Phytochemistry 1983; 22(5): 1159-1162.
26.King BL, Jones SB: Chemosystematics of Vernonia series flexuosae (Vernonieae: Compositae). Bull Torrey Bot Club 1982; 109: 279-286.
27.Nair Agr, Gunasegaran R, Joshi BS: Chemical investigation of certain South Indian plants. Indian J Chem 1982; 216 : 979-980.
28.Odusanya SA, Songonuga OO, Folayan JO: Fluoride-Ion distribution in some African chewing sticks. Ircs Med Sci-Dentistry & Oral Biology 1979; 7: 580-.
29.Igile GO, Oleszek W, Jurzysta M, Burda S, Fafunso M, Fasanmade AA: Flavonoids from Vernonia amygdalina and their antioxidant activities. J Agr Food Chem 1994; 42(11): 445-448.
30.Mabry TJ, Abdel-Baset Z, Padolina WG, Jones JR SB: Systematic implications of flavonoids and sesquiterpene lactones in species of Vernonia. Biochem Syst Ecol 1975; 2 : 185-.
31.Hiserez F, Potterat O, Marston A, Mungai GM, Hostetthann K: Flavonol glycosides from Vernonia galaiknsis ssp. nairobiensis. Phytochemistry 1996; 43(1): 283-286.
32.Tandon M, Shukla YN: Some chemical constituents from Vernonia cinerea. Indian Drugs 1995; 32(3): 132-133.
33.Bohlmann F, Miller L, Gupta RK, King RM, Robinson H: Naturally occuring terpene derivatives. Part 362. Hirsutinolides from Vernonia species. Phytochemistry 1981; 20: 2233-2237.
34.Misra TN, Singh RS, Upadhyay J, Srivastava R: Isolation of a natural sterol and an aliphatic acid from Vernonia cinerea. Phytochemistry 1984; 23(2): 415-417.
35.Swanson CL, Buchanan RA, Otey FH: Molecular weights of natural rubbers from selected temperate zone plants. J Appl Polym Sci 1979; 23: 743-748.
36.Japukovic J, Gage DA, Bohlmann F, Mabry TJ: Sesquiterpene lactones from Vernonia marginata. Phytochemistry 1986; 25(5): 1119-1183.
37.Akupovic J, Schmeda-Hirschmann G, Schuster A, Zdero C, Bohlmann F, Klg RM, Robinson H, Pickaro J: Hirsutionolides, glaucolides and sesquiterpene lactone from Vernonia species. Phytochemistry 1986; 25(1): 145-158.
38.Benoit F, Valentin A, Pelissier Y, Oiafouka F, Marion C, Kone-Bamba D, Kone M, Mallie M, Yapo A, Basttide JM: In vitro antimalarial activity of vegetal, extracts used in west african traditional medicine. Amer J Trop Wed Hyc 1996; 54(1): 67-71.
39.Nestor PS: Phytochemical study of Cuban species of genus Vernonia. Rev Cubana Farh 1984; 18(3): 326-360.
40.Ganjian I, Kubo I, Fludzinski P: Insect antifeedant elemanolide lactones from Vernonia amygdalina. Phytochemistry 1983; 22(11): 2525-2529.
41.Bohlmann F, Jakupovic J, Gupta RK, King RM, Robinson H: Naturally occurring terpene derivatives. Part 296. Allenic germacranolides, bourbonene derived lactones and other constituents from Vernonia species. Phytochemistry 1981; 20: 473-480.
42.Zoero C, Bohlmann F, Uasshausen DC, Nungai HG: Glaucolides from old world Vernonia species. Phytochemistry 1991; 30(12): 4025-4028.
43.Misra TN, Singh RS, Upadhyay J, Srivastava R: Chemical constituents of Vernonia cinerea: isolation and structure elucidation of a new pentaclic triterpenoid. J Nat Prod 1984; 47(5): 865-867.
44.Siigh RK, Singh P, Joshi KC: Glaucolide A and B froh Vernonia elaegnifolia. Fitoterapia 1987; 58(2): 127-128.
45.Jisaka M, Okigashi H, Takagaki T, Nozaki H, Tada T, Hirota M, Irie R, Huffman HA, Nishida T, Kajie M, Koshimizu K: Bitter steroid glucosides, Vernoniosides Al, A2, and A3, and related Bl from a possible medicinal plant, Vernonia amygdalina, used by wild Chimpanzees. Tetrahedron 1992; 48(4): 625-632.
46.Schnittnann T, Rotscheiot K, Breitmaior E: Three new steroid saponins from Vernonia amygoalina (Compositae). J Prakt Chem 1994; 336(3): 225-232.
47.白亦莉,婁傳,劉永隆:大葉斑鳩菊(Vernonia volkameriaefolia)化學成分的研究。中草藥 1985;16(12):530-532。
48.Catalan CAN, DE Iglesias DIA, Kavka J, Sosa VE, Herz U: Sesquiterpene lactones and other constituents of Vernonia hollissima and Verononia squamulosa. J Nat Prod 1986; 49(2): 351-353.
48.Noriega Y, Santana AI, Gupta MP, Monge A, Karikas GA, Lopez DE Cerain A, Solis PN, De Leon E, Trujillo M, Suarez O, Uilson F, Montenegro G, Correa H, Sanchez C: Screening of Panamanian medicinal plants for brine shrimp toxicity, crown gall tumor inhibition, cytotoxicity and DNA intercalation. Int J Pharmacog 1996; 34(1): 19-27.
49.Perdue JR RE, Tsichritzis F, Jakupovic J: Prevernocistifolides from Vernonia galamensis. Phytochemistry 1993; 34(4): 1075-1077.
50.Bohlmann F, Gupta RK, Jakupovic J, King RH, Robinsom H: Acturally occurring terpene derivatives. Part 292. The first sesquiterpene lactone with an allenic group. Liebigs Ann Chem 1980; 1904-1906.
51.Chiappeta ADA, De Mello JF: Higher plants with biological activity. Plants of Pernambuco. II. III. Rev Inst Antibiot Univ Fed Pernambuco Recife H 1984; 1/2.
52.Igile GO, Oleszek W, Burda S, Jurzysta M: Nutritional assessment of Vernoila amygdalina leaves in growing mice. J Agr Food Chem 1995; 43(8): 2162-2166.
53.Chen CP, Lin CC, Namba: Screening of Taiwanese crude drugs for antibacterial activity against Streptococcus mutans. J Ethnopharmacol 1989; 27(3): 285-295.
54.Desta B: Ethiopian traditional herbal drugs. Part II: Antimicrobial activity of 63 medicinal plants. J Ethnopharmacol 1993; 39(2): 129-139.
55.Alarcon MCBV, Lopes JLC, Herz W, Glaucolide B: A molluscicidal sesquiterpene lactone, and other constituents of Vernonia erekophila. Planta Med 1990; 56(3): 271-273.
56.Venkitaraman S, Radhakrishnan N: Hypotensive action of Vernonia cinerea preliminary study. Indian J Physiol Pharmacol 1972; 16: 263-.
57.Lieander-chanco C, Herrera CL, Balgos NS: Tumor inhibitors II. Chemical contituents of Vernonia patula Merr. Philipplen J SCI L 1976; 5: 1-7.
58.Dhar ML, Dhar MM, Dhauan BN, Mehrotra BN, Ray C: Screening of indian plants for biological activity Part 1. Indian J Exp Biol 1968; 6: 232-247.
59.Vlietinck AJ, Van Hoof L, Totte J, Lasure A, Vanden Berghe D, Ruangabo PC, Mvukiyuhuahi J: Screening of hundred rwandese medicinal plants for antimicrobial and antiviral properties. J Ethnopharmacol 1995; 46(1): 31-47.
60.Van Hoof L, Berghe OAV, Vlietinck AJ: 3-methoxyflavones, antivirally active substances from higher plants. Pharm Weekbl (Sci Ed) 1987; 9(4): 226-.
61.Fournet A, Barrios AA, Hunoz V: Leishmanicidal and trypanocidal activities of Bolivian medicinal plants. J Ethnopharmacol 1994; 41(1/2): 19-37.
62.Laekehan GM, Mertens J, Totte J, Bult H, Vlietinck AJ, Herman AG: Isolation and pharmacological characterization of vernolepin. J Nat Prod 1983; 46(2): 161-169.
63.Muir CK: Depressant action of an extract of Vernonia cinerea. Med J Malays 1981; 36: 119-121.
64.Dhawan BN, Patnaik GK, Rastogi RP, Singh KK, Tandon JS: Screening of indian plants for biological activity. VI. Indian J Exp Biol 1977; 15: 200-219.
65.Chagnon M: General pharmacologic inventory of medicinal plants of Rwanda. J Ethnopharmacol 1984; 12(3): 239-251.
66.Obobaseiki-Ebor EE, Odukova K, Telikepalli H, Mitscher LA, Shankel DM: Antimutagenic activity of extracts of leaves of four common edible vegetable plants in Nigeria (West Africa). Mutat Res 1993; 302(2): 109-117.
67.Regenerative, and total DNA concentration in regenerating and Oruambo IF: Alteration of glucose-6-phosphatase activity and normal rat liver of aqueous extracts of two Nigerian plants. J Environ Pathol Toxicol Oncol 1989; 92: 191-199.
68.Akah PA, Okafor CL: Blood sugar lowering effect of Vernonia amygdalima Del, in an experimental rabbit model. Phytother Res 1992; 63: 171-173.
70.Achola K.J, Muangi JU, Muenge RU, Muaura AM: Pharmacological activities of Vernonia glabra. Int J Immunopharmacol 1996; 34(2): 141-144.
71.Frutuoso VS, Gurjao MRR, Cordeiro RSB, Martins NA: Analgesic and anti-lcerogenic effects of a polar extract from leaves of Vernonia condensata. Planta Med 1994; 60(1): 21-25.
72.Hakizamungu E, Van Puyvelde L, Wery M: Screening of Rwandese medicinal plants for anti-trichomonas activity. J Ethnopharmacol 1992; 36(2): 143-146.
73.Freiburghaus F, Ogual EN, Knunya MHH, Kahinsky R, Brun R: In vitro antitrypanosomal activity of African plants used in traditonal medicine in Uganda to treat sleeping sickness. Trop Ked Int Health 1996; 1(6): 765-771.
74.Consoli Ragb, Mendes NM, Pereira JP, Santos BDS, Lamounier HA: Larvicidal properties of plant extracts against Aedes fluviatilis Lutz (Diptera: Culicidae) in the laboratory. Mem Inst Oswaldo Cruz Rio De Janeiro 1988; 83(1): 87-92.
75.Rojas DE, Arias A, Ferro E, Inchausti A, Ascurra M, Acosta N, Rodriguez E, Fournet A: Mutagenicity, insecticidal and trypanocidal activity of some Paraguayan Asteraceae. J Ethnopharmacol 1995; 45(1): 35-41.
76.Ottendorfer D, Frevert J, Kaufmann R, Beuscher N, Booinet C, Hsonthi JD, Marston A, Hostettman K: Enhancement of in vitro nonspecific immune functions by African plant extracts. Phytother Res 1994; 8(7): 383-.
77.Sandberg F, Cronlund A: What can we still learn from traditional folklore medicine? examples from the results of a biological screening of medicinal plants from Equatorial Africa. Proc Third Asian Symposium Med Plants & Spices Colombo Sri Lanka February 1997; 6-12(3): 178-197.
78.Kone-Bamba D, Pelissier Y, Ozoukou ZF, Kouao D: Hemostatic activity of 216 plants used in traditioual medicine in the Ivory Coast. Plant Med Phytother 1987; 21(2): 122-130.
79.Litchfied JT, Wilcoxon F: A simplified methods of elevating dose effect experiment. J Pharmacol Exp Ther 1949; 96: 99-113.
80.Rosland JH, Tjolsen A, Mahle B, Hole K: The formalin test in mice: effect of formalin concentration. Pain 1990: 235-242.
81.陳玉芳:臺灣產藜蘆與芍藥對於中樞神經系統相互作用之藥理學研究,中國醫藥學院中國藥學研究所藥學碩士論文,台中1986; 10-11。82.闕甫:八角楓分離物對於中樞神經系統與腦內單胺濃度之影響,中國醫藥學院中國藥學研究所碩士論文,台中1990; 10。
83.林美昭、林宗旦編著:最新植物化學,明哲出版社,1977:573-583。
84.肖崇厚、陳蘊如:中藥化學,上海科學技術出版社,1992:354-360。
85.Lai JS, Liou HS, Huang KF: Constituents of the roots of Melanolepis multiglandulosa. Chin Pharm J 1996; 48: 177-183.
86.Huang KF, Yen YF: Constituents of Erythrina variegata. Chin Pharm J 1997; 49: 21-29.
87.江紀武、肖慶祥:植物藥有效成分手冊,人民衛生版社,1986。
88.Charles J .Pouchert, Jacqlynn, Behnke: The aldrich library of 13C and 1H ft NMR spectra 1993; 1(1): 785.
89.張瓊文:一.植物活性成分研究1.羅勒 (Ocimum basilicum L.) 2.台灣赤楠(Syzygium formosanum) ;二. Naringin與hesperidin之高效液相層析定量。中國醫藥學院藥物化學研究所 1997:39。90.Koji Nakanishi: 1H-NMR of methyl 9,12-Octadecadienoate (with shift reagent), one-dimensional and two-dimensional NMR spectra by modern pulse techniques. University Science Books 1990: 6.
91.Kuo YH, Yeh MH: Chemical constituents of heartwood of Bauhinia purpurea. J Chin Chem Soc 1997; 44: 379-383.
92.Bengsch E, Perly B, Deleuze C, Valero A: A General rule for the assignment of the carbon-13 NMR peaks in fatty acid chains. J Magn Reson 1986; 68(1): 1-13.
93.Baranyai M, Molnar P, Szabolcs: Determination of the geometric configuration of the polyene chain of mono-sis C40 cartenoids II. Tetrahrdron 1981; 37: 203-207.
94.Achenbach H, Lottes M, Waibel R, Karikas George A, Correa Mireya D, Gupta Mahabir P: Alkaloids and other compounds from Psychotria correae. Phytochemistry 1995; 38(6): 1537-1546.
95.Bucheckdf R, Hamm P, Rugster CH: Absloute Konfiguration von Xanthophyll (Lutein). Helv Chim Acta 1974; 57: 631-656.
96.Mackowiak PA: Fever: Basic mechanisms and management. Raven Press New York 1991: 1-70.
97.Rietschel ET and Brade H: Bacterial endotoxins. Scientific americant. 1992; 8: 54-61.
98.Kent S, Bluthe RM, Kelley KW, Dantzer R: Sickness behavior as a new target for drug development. Trends Pharmacol Sciences 1992; 13: 24-28.
99.Yirmiya R: Endotoxin produces a depressive like episode in rats. Brain Res 1996; 7(11): 163-168.
100.Rothwell NJ, Hopkins SJ: Cytokines and the nervous system II: Actions and mechanisms of actions. Trends Neurosci 1995; 18: 130-136.
101.Rothwell NJ: CNS regulation of thermogenesis. Citrc Rev Neurobiol 1994; 8: 1-10.
102.Rietschel E, Kirikae T, Schade U: Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217-225.
103.Dascombe MJ: The pharmacology of hyperthermia. Prog Neurobiology 1985; 25: 327-373.
104.Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550-552.
105.Dinarello CA, Cannon JG, Wolff SM: New concepts on the pathogenesis of fever Rev Infect Dis 1988; 10: 168-189.
106.Dinarello CA: Endogenous pyrogens: The role of cytokines in the pathgenesis of fever. Fever: basic mechanisms and management. New York: Raven Press. 23-48.
107.Kluger MJ: Role of pyrogens and cryogen. Physiol Rev 1991; 71: 93-127.
108.Breder CD, Dinarello CA, and Saper CB: Interleukin-1 immuno-reactive innervation of the human hypothalamus. Science 1988; 240: 321-323.
109.Lechan RM, Toni R, Clark BD, Cannon, J G, Shaw AR, Dinarello CA and Reichlin S. Immunoreactive interleukin-1b localization in the rat forebrain. Brain Res 1989; 514: 135-140.
110.Blatteis CM: Neural mechanisms in the pyrogenic and acute phase responses to interleukin-1. Int J Neurosci 1988; 38: 223-232.
111.Rothwell NJ: Mechanisms of the pyrogenic effects of cytokines. E Cytokin Network 1990; 1: 211-213.
112.Busbridge NJ, Dascombe MJ, Tilders FJH: Central activation of therrnogenesis and fever by interleukin-lb and interleukin-la involves different mechanism. Biochem Biophys Res Commun 1989; 162: 591-596.
113.Opp MR, Krueger JM: Interleukin-1 receptor antagonist blocks interleukin-1 induced sleep and fever. Am J Physiol 1991; 260: 453-457.
114.Akio M, Naotoshi M, Yoshiyuki S: Functional and structural difference in febrile mechanism between rabbits and rats. J Physiol (London) 1990; 427: 227-239.
115.謝文聰,蔡輝彥,謝明村,陳介甫:紫背一點廣鎮痛抗炎作用及其有效成分之研究,中國醫藥學院雜誌 1992; 1(1): 45-53.116.Dubuisson D and Dennis SG: The formalin test: a quantitative study of the analgesic effects of morphin, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-174.
117.Otani A and Hugli TE: Leukocyte chemotaxis: a new in vivo testing technique. Inflammation 1997; 2: 67-82.
118.Shibata M, Ohkubo T, Takahashi H, Inoki R: Modified formalin test: characteristic biphasic pain response. Pain 1989: 338-347.
119.Rosland JH, Tjolsen A, Mahle B, Hole K: The formalin test in mice: effect of formalin concentration. Pain 1990: 235-242.
120.Johnston, GAR: Neuropharmacology of amine and inhibitory transmitters. In. The pharmacological bases of therapeutics, 6th ed. (Gilman A.G., Goodman, L.S., Gilman A., eds) Macmillan Publishing Co., Inc. New York, 1952: 586-587.
121.Tanaka K: Studies on Veratrum alkaloids XX. Action of Veraturm alkaloids upon the central nervous system of mice. J Pharmacol Exptl Therap 1952; 104: 76-78.
122.Esoline, DW, Curto EM: Effect of trimethadione and pentylenetetrazole. In, the pharmacological basis of therapeutics. 6th ed. (Gliman AG, Goodman LS, Gilman A, eds) Macmillan Publishing Co., Inc. New York 1980: 588.
123.Velasco F, Velasco M, Romo R,: Push-pull perfusion of pentylenetetrazole in the brian atem of encephale isole cats. Electroencephalogr. Clin Neurophysiol 1983; 56(5): 521-527.